SCHEMBL21600992

SCHEMBL21600992

C=CC(=O)Nc1cc(N2CCC(N(C)C)CC2)c(C)cc1Nc1ncc(C#N)c(-c2c[nH]c3ccccc23)n1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 15/20 0.53
▸ CDK7 P50613 4/20 0.49
▸ CCNH P51946 4/20 0.49
▸ MNAT1 P51948 3/20 0.49
▸ CDK1 P06493 1/20 0.49
▸ CCNB1 P14635 1/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ CCNT1 O60563 2/20 0.49
▸ CCNA2 P20248 2/20 0.49
▸ CDK2 P24941 2/20 0.49
▸ CDK9 P50750 2/20 0.49
▸ IGF1R P08069 4/20 0.47
▸ KCNH2 Q12809 4/20 0.47
▸ CDK5 Q00535 1/20 0.46
▸ CDK5R1 Q15078 1/20 0.46
▸ INSR P06213 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21600994 0.93 CDK7 (0.54) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21600990 0.93 EGFR (0.57) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL28537409 0.90 EGFR (0.58) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL19467707 0.85 EGFR (0.65) EGFRCDK7CCNHMNAT1CCNT1
SCHEMBL21601031 0.83 EGFR (0.62) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21601034 0.83 CDK7 (0.54) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21600996 0.82 CDK7 (0.53) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21601000 0.81 EGFR (0.54) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL21600993 0.81 EGFR (0.54) EGFRCDK7CCNHMNAT1CDK1
SCHEMBL14663490 0.80 EGFR (0.81) EGFRCDK7CCNHMNAT1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019242689-A1 CYANO-SUBSTITUTED PYRIDINE AND CYANO-SUBSTITUTED PYRIMIDINE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2019-12-26 — — WO disclosed
Send feedback